News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Aegle Therapeutics Corp. Shares Positive Outcomes for the First Participant in Phase 1/2a Clinical Trial Treated with AGLE-102™, a Novel Extracellular Vesicle Therapy
Tuesday, January 09, 2024Aegle Therapeutics Corp has revealed positive results from the initial week evaluation of the first participant in its Phase a clinical trial for AGLE an innovative extracellular vesicle
Orion and Glykos Announce a Collaborative Research Initiative and Licensing Agreement Aimed at Advancing the Development of Next-generation ADCs
Monday, January 08, 2024Orion Corporation and Glykos Finland Oy have jointly announced a research collaboration and licensing agreement for the development of nextgeneration antibodydrug conjugates
Essential Pharma Obtains European Rights to Colobreathe® (Colistimethate Sodium) Through Acquisition From Teva
Monday, January 08, 2024Essential Pharma an international specialty pharmaceutical group committed to providing sustainable access to lowvolume clinically established pharmaceutical products in key therapeutic areas has successfully concluded the acquisition
Nimbus Therapeutics Unveils Enlargement of Its Immunology Drug Discovery Pipeline
Saturday, January 06, 2024Nimbus Therapeutics LLC a biotechnology company known for its innovative computational drug discovery engine has announced the expansion and advancement of its pipeline by introducing discovery programs targeting innate immunity pathways
Rivus Pharmaceuticals has successfully concluded the enrollment phase for the Phase 2a HuMAIN Trial of HU6
Saturday, January 06, 2024Rivus Pharmaceuticals Inc a clinicalstage biopharmaceutical company dedicated to enhancing cardiometabolic health has successfully concluded the enrollment phase for its Phase a HuMAIN trial of HU HU
Anocca Secures GMP Manufacturing License for Advancing Innovative KRAS TCR-T Cell Therapies in Clinical Development
Friday, January 05, 2024Anocca AB a prominent company specializing in T cell receptorengineered T cell therapies has announced that it has received a certificate of good manufacturing practice compliance
Menarini & Insilico Medicine's Global License for KAT6 Inhibitor in Breast Cancer Treatment
Friday, January 05, 2024The Menarini Group a major international pharmaceutical and diagnostics company in collaboration with its subsidiary Stemline Therapeutics and Insilico Medicine a clinicalstage AIdriven biotechnology firm
Apertura Gene Therapy Reveals Newly Engineered AAV Capsids Tailored for Human Transferrin Receptor 1 in Advancing Neurological Gene Therapy Delivery
Friday, January 05, 2024Apertura Gene Therapy a biotechnology company has introduced its proprietary engineered AdenoAssociated Virus capsids designed to target the human Transferrin Receptor
Ribo and Boehringer Ingelheim Collaborate to Create Innovative Treatments for Individuals With Liver Diseases
Thursday, January 04, 2024Suzhou Ribo Life Science Co Ltd and Ribocure AB have jointly announced a collaboration with Boehringer Ingelheim to develop novel treatments for nonalcoholic or metabolic dysfunctionassociated steatohepatitis
Tome Biosciences Successfully Acquires Replace Therapeutics
Wednesday, January 03, 2024Tome Biosciences Inc has recently completed the acquisition of Replace Therapeutics Inc a privatelyheld biotechnology company specializing in a novel programmable genomic integration method designed for the insertion
